CVS Health Corp (CVS, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. CVS Health Corp operates in the healthcare sector. Its primary business is that of operating retail pharmacies. The company has three reportable segments namely Pharmacy Services, Retail/LTC, and Corporate. CVS Health Corp has a market cap of $93.36 billion; its shares were traded at around $71.76 with a P/E ratio of 14.12 and P/S ratio of 0.36. The dividend yield of CVS Health Corp stocks is 2.79%. CVS Health Corp had annual average EBITDA growth of 7.70% over the past ten years. GuruFocus rated CVS Health Corp the business predictability rank of 5-star. GuruFocus has detected 3 severe warning signs with CVS Health Corp. .
For the last quarter CVS Health Corp reported a revenue of $66.9 billion, compared with the revenue of $54.9 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $256.8 billion, an increase of 32% from last year. For the complete 30-year financial data, please go here.. For the last five years CVS Health Corp had an average revenue growth rate of 11.5% a year.
The reported diluted earnings per share was $5.08 for the year, an increase of -991.2% from previous year. The CVS Health Corp had an operating margin of 4.67%, compared with the operating margin of 5.23% a year before. The 10-year historical median operating margin of CVS Health Corp is 5.89%. The profitability rank of the company is 8 (out of 10).
At the end of the fiscal year, CVS Health Corp has the cash and cash equivalents of $5.7 billion, compared with $4.1 billion in the previous year. The long term debt was $83.6 billion, compared with $71.4 billion in the previous year. The interest coverage to the debt is 3.9. CVS Health Corp has a financial strength rank of 4 (out of 10).
At the current stock price of $71.76, CVS Health Corp is traded at 28.4% discount to its historical median P/S valuation band of $100.26. The P/S ratio of the stock is 0.36, while the historical median P/S ratio is 0.51. The intrinsic value of the stock is $54.36 a share, according to GuruFocus DCF Calculator. The stock gained 8.39% during the past 12 months.
For the complete 20-year historical financial data of CVS, click here.
